nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.13	0.519	CrCtD
Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.12	0.481	CrCtD
Daunorubicin—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.0796	0.236	CiPCiCtD
Daunorubicin—Anthracyclines—Epirubicin—peripheral nervous system neoplasm	0.07	0.207	CiPCiCtD
Daunorubicin—Anthracyclines—Doxorubicin—peripheral nervous system neoplasm	0.0647	0.192	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0531	0.157	CiPCiCtD
Daunorubicin—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.0366	0.108	CiPCiCtD
Daunorubicin—ABCB1—peripheral nervous system neoplasm	0.0355	1	CbGaD
Daunorubicin—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0338	0.1	CiPCiCtD
Daunorubicin—Valrubicin—Epirubicin—peripheral nervous system neoplasm	0.0278	0.173	CrCrCtD
Daunorubicin—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.0278	0.173	CrCrCtD
Daunorubicin—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.0278	0.173	CrCrCtD
Daunorubicin—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.0257	0.16	CrCrCtD
Daunorubicin—Valrubicin—Doxorubicin—peripheral nervous system neoplasm	0.0257	0.16	CrCrCtD
Daunorubicin—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.0257	0.16	CrCrCtD
Daunorubicin—YWHAG—Epirubicin—peripheral nervous system neoplasm	0.0215	0.129	CbGbCtD
Daunorubicin—TOP2B—Etoposide—peripheral nervous system neoplasm	0.0168	0.101	CbGbCtD
Daunorubicin—YWHAG—Doxorubicin—peripheral nervous system neoplasm	0.0114	0.0687	CbGbCtD
Daunorubicin—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.0113	0.0681	CbGbCtD
Daunorubicin—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.00652	0.0391	CbGbCtD
Daunorubicin—ABCC6—Etoposide—peripheral nervous system neoplasm	0.0064	0.0384	CbGbCtD
Daunorubicin—ABCC10—Vincristine—peripheral nervous system neoplasm	0.00534	0.032	CbGbCtD
Daunorubicin—ABCC10—Etoposide—peripheral nervous system neoplasm	0.00489	0.0294	CbGbCtD
Daunorubicin—POR—Doxorubicin—peripheral nervous system neoplasm	0.00475	0.0285	CbGbCtD
Daunorubicin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.00437	0.0262	CbGbCtD
Daunorubicin—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.00437	0.0262	CbGbCtD
Daunorubicin—XDH—Cisplatin—peripheral nervous system neoplasm	0.00407	0.0244	CbGbCtD
Daunorubicin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.00341	0.0204	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00335	0.0201	CbGbCtD
Daunorubicin—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.00334	0.02	CbGbCtD
Daunorubicin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.00323	0.0194	CbGbCtD
Daunorubicin—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0029	0.0174	CbGbCtD
Daunorubicin—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.00277	0.0166	CbGbCtD
Daunorubicin—XDH—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.0164	CbGbCtD
Daunorubicin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.00242	0.0145	CbGbCtD
Daunorubicin—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.00238	0.0143	CbGbCtD
Daunorubicin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.0139	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00224	0.0134	CbGbCtD
Daunorubicin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00206	0.0124	CbGbCtD
Daunorubicin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00189	0.0113	CbGbCtD
Daunorubicin—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.0109	CbGbCtD
Daunorubicin—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.0109	CbGbCtD
Daunorubicin—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.00174	0.0105	CbGbCtD
Daunorubicin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00999	CbGbCtD
Daunorubicin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00153	0.00916	CbGbCtD
Daunorubicin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00142	0.00854	CbGbCtD
Daunorubicin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0014	0.00839	CbGbCtD
Daunorubicin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00138	0.00828	CbGbCtD
Daunorubicin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.008	CbGbCtD
Daunorubicin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00773	CbGbCtD
Daunorubicin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00772	CbGbCtD
Daunorubicin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00126	0.00759	CbGbCtD
Daunorubicin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00699	CbGbCtD
Daunorubicin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00117	0.00699	CbGbCtD
Daunorubicin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00107	0.00639	CbGbCtD
Daunorubicin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.00572	CbGbCtD
Daunorubicin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.000862	0.00517	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.000808	0.00485	CbGbCtD
Daunorubicin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.000764	0.00459	CbGbCtD
Daunorubicin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0007	0.0042	CbGbCtD
Daunorubicin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.000698	0.00419	CbGbCtD
Daunorubicin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.000649	0.00389	CbGbCtD
Daunorubicin—Epirubicin—AURKA—peripheral nervous system neoplasm	0.000633	0.61	CrCbGaD
Daunorubicin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.000521	0.00313	CbGbCtD
Daunorubicin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.000497	0.00298	CbGbCtD
Daunorubicin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.000464	0.00278	CbGbCtD
Daunorubicin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.000456	0.00274	CbGbCtD
Daunorubicin—Doxorubicin—AURKA—peripheral nervous system neoplasm	0.000363	0.35	CrCbGaD
Daunorubicin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.00187	CbGbCtD
Daunorubicin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000298	0.00179	CbGbCtD
Daunorubicin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000273	0.00164	CbGbCtD
Daunorubicin—TOP2B—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000203	0.286	CbGdCrCtD
Daunorubicin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00112	CbGbCtD
Daunorubicin—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000181	0.255	CbGdCrCtD
Daunorubicin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	8.76e-05	0.123	CbGdCrCtD
Daunorubicin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	5.2e-05	0.0732	CbGdCrCtD
Daunorubicin—Doxorubicin—ABCB1—peripheral nervous system neoplasm	4.15e-05	0.04	CrCbGaD
Daunorubicin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	3.28e-05	0.0462	CbGdCrCtD
Daunorubicin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	3.28e-05	0.0462	CbGdCrCtD
Daunorubicin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	3.28e-05	0.0462	CbGdCrCtD
Daunorubicin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	2.26e-05	0.0318	CbGdCrCtD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.78e-05	0.00178	CbGpPWpGaD
Daunorubicin—YWHAG—mTOR signaling pathway—AKT1—peripheral nervous system neoplasm	1.78e-05	0.00178	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MET—peripheral nervous system neoplasm	1.77e-05	0.00177	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.76e-05	0.00176	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.75e-05	0.00175	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.72e-05	0.00172	CbGpPWpGaD
Daunorubicin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	1.71e-05	0.0241	CbGdCrCtD
Daunorubicin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	1.71e-05	0.0241	CbGdCrCtD
Daunorubicin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	1.7e-05	0.000457	CcSEcCtD
Daunorubicin—Headache—Topotecan—peripheral nervous system neoplasm	1.7e-05	0.000457	CcSEcCtD
Daunorubicin—Rash—Isotretinoin—peripheral nervous system neoplasm	1.7e-05	0.000456	CcSEcCtD
Daunorubicin—Rash—Tretinoin—peripheral nervous system neoplasm	1.7e-05	0.000456	CcSEcCtD
Daunorubicin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	1.7e-05	0.000456	CcSEcCtD
Daunorubicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	1.69e-05	0.000456	CcSEcCtD
Daunorubicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	1.69e-05	0.000456	CcSEcCtD
Daunorubicin—Fatigue—Vincristine—peripheral nervous system neoplasm	1.69e-05	0.000456	CcSEcCtD
Daunorubicin—Convulsion—Etoposide—peripheral nervous system neoplasm	1.69e-05	0.000454	CcSEcCtD
Daunorubicin—Vomiting—Melphalan—peripheral nervous system neoplasm	1.69e-05	0.000454	CcSEcCtD
Daunorubicin—Dehydration—Epirubicin—peripheral nervous system neoplasm	1.69e-05	0.000454	CcSEcCtD
Daunorubicin—Headache—Isotretinoin—peripheral nervous system neoplasm	1.69e-05	0.000453	CcSEcCtD
Daunorubicin—Headache—Tretinoin—peripheral nervous system neoplasm	1.69e-05	0.000453	CcSEcCtD
Daunorubicin—Hypertension—Etoposide—peripheral nervous system neoplasm	1.68e-05	0.000453	CcSEcCtD
Daunorubicin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Daunorubicin—Pain—Vincristine—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Daunorubicin—Constipation—Vincristine—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Daunorubicin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Daunorubicin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	1.68e-05	0.000452	CcSEcCtD
Daunorubicin—Rash—Melphalan—peripheral nervous system neoplasm	1.67e-05	0.00045	CcSEcCtD
Daunorubicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	1.67e-05	0.00045	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	1.67e-05	0.000448	CcSEcCtD
Daunorubicin—Dry skin—Epirubicin—peripheral nervous system neoplasm	1.66e-05	0.000447	CcSEcCtD
Daunorubicin—Chest pain—Etoposide—peripheral nervous system neoplasm	1.66e-05	0.000447	CcSEcCtD
Daunorubicin—YWHAG—Apoptosis—CASP3—peripheral nervous system neoplasm	1.66e-05	0.00166	CbGpPWpGaD
Daunorubicin—Anorexia—Cisplatin—peripheral nervous system neoplasm	1.66e-05	0.000445	CcSEcCtD
Daunorubicin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000445	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	1.65e-05	0.00165	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.65e-05	0.00165	CbGpPWpGaD
Daunorubicin—Discomfort—Etoposide—peripheral nervous system neoplasm	1.64e-05	0.000441	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	1.64e-05	0.00163	CbGpPWpGaD
Daunorubicin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.00163	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—AURKA—peripheral nervous system neoplasm	1.63e-05	0.00163	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.63e-05	0.00163	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	1.62e-05	0.000436	CcSEcCtD
Daunorubicin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	1.62e-05	0.000436	CcSEcCtD
Daunorubicin—XDH—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.61e-05	0.00161	CbGpPWpGaD
Daunorubicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	1.61e-05	0.000433	CcSEcCtD
Daunorubicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	1.61e-05	0.000433	CcSEcCtD
Daunorubicin—Nausea—Topotecan—peripheral nervous system neoplasm	1.61e-05	0.000433	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	1.61e-05	0.000432	CcSEcCtD
Daunorubicin—Gastritis—Epirubicin—peripheral nervous system neoplasm	1.61e-05	0.000432	CcSEcCtD
Daunorubicin—Confusional state—Etoposide—peripheral nervous system neoplasm	1.6e-05	0.000432	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.6e-05	0.0016	CbGpPWpGaD
Daunorubicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	1.6e-05	0.00043	CcSEcCtD
Daunorubicin—Nausea—Tretinoin—peripheral nervous system neoplasm	1.6e-05	0.00043	CcSEcCtD
Daunorubicin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	1.6e-05	0.00043	CcSEcCtD
Daunorubicin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	1.59e-05	0.000428	CcSEcCtD
Daunorubicin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	1.59e-05	0.000428	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	1.58e-05	0.00158	CbGpPWpGaD
Daunorubicin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	1.58e-05	0.000426	CcSEcCtD
Daunorubicin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.0223	CbGdCrCtD
Daunorubicin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.0223	CbGdCrCtD
Daunorubicin—Infection—Etoposide—peripheral nervous system neoplasm	1.58e-05	0.000425	CcSEcCtD
Daunorubicin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000425	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	1.58e-05	0.000424	CcSEcCtD
Daunorubicin—Nausea—Melphalan—peripheral nervous system neoplasm	1.58e-05	0.000424	CcSEcCtD
Daunorubicin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	1.57e-05	0.000422	CcSEcCtD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	1.56e-05	0.00156	CbGpPWpGaD
Daunorubicin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	1.56e-05	0.00042	CcSEcCtD
Daunorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	1.56e-05	0.00156	CbGpPWpGaD
Daunorubicin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	1.56e-05	0.000419	CcSEcCtD
Daunorubicin—Tachycardia—Etoposide—peripheral nervous system neoplasm	1.55e-05	0.000418	CcSEcCtD
Daunorubicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	1.55e-05	0.000418	CcSEcCtD
Daunorubicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	1.55e-05	0.000418	CcSEcCtD
Daunorubicin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	1.55e-05	0.000417	CcSEcCtD
Daunorubicin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.000414	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	1.54e-05	0.00154	CbGpPWpGaD
Daunorubicin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	1.54e-05	0.000414	CcSEcCtD
Daunorubicin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000411	CcSEcCtD
Daunorubicin—Anorexia—Etoposide—peripheral nervous system neoplasm	1.52e-05	0.000408	CcSEcCtD
Daunorubicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	1.51e-05	0.000406	CcSEcCtD
Daunorubicin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	1.5e-05	0.000405	CcSEcCtD
Daunorubicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	1.5e-05	0.000404	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	1.49e-05	0.00149	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	1.49e-05	0.00149	CbGpPWpGaD
Daunorubicin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	1.49e-05	0.000401	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—TP53—peripheral nervous system neoplasm	1.49e-05	0.00148	CbGpPWpGaD
Daunorubicin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	1.49e-05	0.0004	CcSEcCtD
Daunorubicin—Pain—Cisplatin—peripheral nervous system neoplasm	1.49e-05	0.0004	CcSEcCtD
Daunorubicin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000395	CcSEcCtD
Daunorubicin—Dysuria—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000395	CcSEcCtD
Daunorubicin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	1.46e-05	0.000393	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1.46e-05	0.00145	CbGpPWpGaD
Daunorubicin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	1.45e-05	0.00039	CcSEcCtD
Daunorubicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	1.45e-05	0.000389	CcSEcCtD
Daunorubicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	1.44e-05	0.000388	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	1.44e-05	0.00144	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	1.43e-05	0.000385	CcSEcCtD
Daunorubicin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	1.42e-05	0.000382	CcSEcCtD
Daunorubicin—Somnolence—Etoposide—peripheral nervous system neoplasm	1.42e-05	0.000381	CcSEcCtD
Daunorubicin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.00038	CcSEcCtD
Daunorubicin—Asthenia—Vincristine—peripheral nervous system neoplasm	1.41e-05	0.000379	CcSEcCtD
Daunorubicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	1.4e-05	0.000376	CcSEcCtD
Daunorubicin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	1.4e-05	0.000375	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—HRAS—peripheral nervous system neoplasm	1.39e-05	0.00139	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.39e-05	0.00138	CbGpPWpGaD
Daunorubicin—Rash—Dactinomycin—peripheral nervous system neoplasm	1.39e-05	0.000373	CcSEcCtD
Daunorubicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	1.38e-05	0.000372	CcSEcCtD
Daunorubicin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.000371	CcSEcCtD
Daunorubicin—Renal failure—Epirubicin—peripheral nervous system neoplasm	1.38e-05	0.00037	CcSEcCtD
Daunorubicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	1.37e-05	0.000369	CcSEcCtD
Daunorubicin—Fatigue—Etoposide—peripheral nervous system neoplasm	1.37e-05	0.000369	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	1.37e-05	0.000369	CcSEcCtD
Daunorubicin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	1.36e-05	0.000367	CcSEcCtD
Daunorubicin—Pain—Etoposide—peripheral nervous system neoplasm	1.36e-05	0.000366	CcSEcCtD
Daunorubicin—Constipation—Etoposide—peripheral nervous system neoplasm	1.36e-05	0.000366	CcSEcCtD
Daunorubicin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	1.36e-05	0.000366	CcSEcCtD
Daunorubicin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000365	CcSEcCtD
Daunorubicin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000365	CcSEcCtD
Daunorubicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	1.35e-05	0.000363	CcSEcCtD
Daunorubicin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	1.34e-05	0.000362	CcSEcCtD
Daunorubicin—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.32e-05	0.00132	CbGpPWpGaD
Daunorubicin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	1.31e-05	0.000353	CcSEcCtD
Daunorubicin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	1.31e-05	0.000353	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.31e-05	0.000351	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	1.3e-05	0.00035	CcSEcCtD
Daunorubicin—Dizziness—Vincristine—peripheral nervous system neoplasm	1.3e-05	0.000349	CcSEcCtD
Daunorubicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.3e-05	0.000349	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.3e-05	0.00129	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.29e-05	0.00128	CbGpPWpGaD
Daunorubicin—Rash—Alitretinoin—peripheral nervous system neoplasm	1.29e-05	0.000346	CcSEcCtD
Daunorubicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.28e-05	0.000345	CcSEcCtD
Daunorubicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.28e-05	0.000344	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.28e-05	0.00128	CbGpPWpGaD
Daunorubicin—Headache—Alitretinoin—peripheral nervous system neoplasm	1.28e-05	0.000344	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	1.28e-05	0.00127	CbGpPWpGaD
Daunorubicin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	1.27e-05	0.000342	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.27e-05	0.00127	CbGpPWpGaD
Daunorubicin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	1.27e-05	0.000341	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—peripheral nervous system neoplasm	1.26e-05	0.00034	CcSEcCtD
Daunorubicin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.26e-05	0.000339	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.26e-05	0.00126	CbGpPWpGaD
Daunorubicin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	1.26e-05	0.000339	CcSEcCtD
Daunorubicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	1.26e-05	0.000338	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	1.26e-05	0.000338	CcSEcCtD
Daunorubicin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	1.26e-05	0.000338	CcSEcCtD
Daunorubicin—Vomiting—Vincristine—peripheral nervous system neoplasm	1.25e-05	0.000336	CcSEcCtD
Daunorubicin—Asthenia—Cisplatin—peripheral nervous system neoplasm	1.25e-05	0.000335	CcSEcCtD
Daunorubicin—Rash—Vincristine—peripheral nervous system neoplasm	1.24e-05	0.000333	CcSEcCtD
Daunorubicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.24e-05	0.000333	CcSEcCtD
Daunorubicin—Headache—Vincristine—peripheral nervous system neoplasm	1.23e-05	0.000331	CcSEcCtD
Daunorubicin—YWHAG—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	1.23e-05	0.00122	CbGpPWpGaD
Daunorubicin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000327	CcSEcCtD
Daunorubicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.21e-05	0.000326	CcSEcCtD
Daunorubicin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	1.21e-05	0.000325	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	1.21e-05	0.00121	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.19e-05	0.00119	CbGpPWpGaD
Daunorubicin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.19e-05	0.00032	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.19e-05	0.00119	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.18e-05	0.00118	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	1.18e-05	0.00118	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.17e-05	0.000315	CcSEcCtD
Daunorubicin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000315	CcSEcCtD
Daunorubicin—Nausea—Vincristine—peripheral nervous system neoplasm	1.17e-05	0.000314	CcSEcCtD
Daunorubicin—XDH—Metabolism—GNS—peripheral nervous system neoplasm	1.17e-05	0.00116	CbGpPWpGaD
Daunorubicin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000313	CcSEcCtD
Daunorubicin—Flushing—Epirubicin—peripheral nervous system neoplasm	1.17e-05	0.000313	CcSEcCtD
Daunorubicin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000313	CcSEcCtD
Daunorubicin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.16e-05	0.00116	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.15e-05	0.00115	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.15e-05	0.00115	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	1.14e-05	0.00114	CbGpPWpGaD
Daunorubicin—Asthenia—Etoposide—peripheral nervous system neoplasm	1.14e-05	0.000307	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	1.14e-05	0.00114	CbGpPWpGaD
Daunorubicin—Chills—Epirubicin—peripheral nervous system neoplasm	1.13e-05	0.000303	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—peripheral nervous system neoplasm	1.13e-05	0.000303	CcSEcCtD
Daunorubicin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.12e-05	0.000302	CcSEcCtD
Daunorubicin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	1.12e-05	0.000301	CcSEcCtD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.12e-05	0.00112	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-05	0.00111	CbGpPWpGaD
Daunorubicin—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.11e-05	0.000298	CcSEcCtD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.11e-05	0.00111	CbGpPWpGaD
Daunorubicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.1e-05	0.000297	CcSEcCtD
Daunorubicin—Rash—Cisplatin—peripheral nervous system neoplasm	1.1e-05	0.000295	CcSEcCtD
Daunorubicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.09e-05	0.000294	CcSEcCtD
Daunorubicin—Erythema—Epirubicin—peripheral nervous system neoplasm	1.09e-05	0.000294	CcSEcCtD
Daunorubicin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.09e-05	0.000293	CcSEcCtD
Daunorubicin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000291	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.00108	CbGpPWpGaD
Daunorubicin—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.00029	CcSEcCtD
Daunorubicin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.00029	CcSEcCtD
Daunorubicin—XDH—Metabolism—COX2—peripheral nervous system neoplasm	1.08e-05	0.00107	CbGpPWpGaD
Daunorubicin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000288	CcSEcCtD
Daunorubicin—YWHAG—Apoptosis—TP53—peripheral nervous system neoplasm	1.06e-05	0.00106	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.06e-05	0.00106	CbGpPWpGaD
Daunorubicin—Back pain—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000284	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.06e-05	0.00105	CbGpPWpGaD
Daunorubicin—Dizziness—Etoposide—peripheral nervous system neoplasm	1.05e-05	0.000283	CcSEcCtD
Daunorubicin—Chills—Doxorubicin—peripheral nervous system neoplasm	1.04e-05	0.00028	CcSEcCtD
Daunorubicin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.04e-05	0.000279	CcSEcCtD
Daunorubicin—Nausea—Cisplatin—peripheral nervous system neoplasm	1.03e-05	0.000278	CcSEcCtD
Daunorubicin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.03e-05	0.000276	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1.02e-05	0.00102	CbGpPWpGaD
Daunorubicin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000273	CcSEcCtD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	1.01e-05	0.00101	CbGpPWpGaD
Daunorubicin—Vomiting—Etoposide—peripheral nervous system neoplasm	1.01e-05	0.000272	CcSEcCtD
Daunorubicin—Erythema—Doxorubicin—peripheral nervous system neoplasm	1.01e-05	0.000272	CcSEcCtD
Daunorubicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000272	CcSEcCtD
Daunorubicin—Agitation—Epirubicin—peripheral nervous system neoplasm	1e-05	0.00027	CcSEcCtD
Daunorubicin—Rash—Etoposide—peripheral nervous system neoplasm	1e-05	0.00027	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	1e-05	0.00027	CcSEcCtD
Daunorubicin—Headache—Etoposide—peripheral nervous system neoplasm	9.97e-06	0.000268	CcSEcCtD
Daunorubicin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.91e-06	0.000266	CcSEcCtD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.88e-06	0.000986	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	9.88e-06	0.000985	CbGpPWpGaD
Daunorubicin—Malaise—Epirubicin—peripheral nervous system neoplasm	9.86e-06	0.000265	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—NRAS—peripheral nervous system neoplasm	9.85e-06	0.000983	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.82e-06	0.00098	CbGpPWpGaD
Daunorubicin—Syncope—Epirubicin—peripheral nervous system neoplasm	9.8e-06	0.000264	CcSEcCtD
Daunorubicin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	9.79e-06	0.000263	CcSEcCtD
Daunorubicin—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.78e-06	0.000263	CcSEcCtD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	9.75e-06	0.000973	CbGpPWpGaD
Daunorubicin—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.66e-06	0.00026	CcSEcCtD
Daunorubicin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	9.61e-06	0.000258	CcSEcCtD
Daunorubicin—Cough—Epirubicin—peripheral nervous system neoplasm	9.54e-06	0.000257	CcSEcCtD
Daunorubicin—Convulsion—Epirubicin—peripheral nervous system neoplasm	9.47e-06	0.000255	CcSEcCtD
Daunorubicin—Nausea—Etoposide—peripheral nervous system neoplasm	9.45e-06	0.000254	CcSEcCtD
Daunorubicin—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.44e-06	0.000254	CcSEcCtD
Daunorubicin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.39e-06	0.000252	CcSEcCtD
Daunorubicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	9.35e-06	0.000251	CcSEcCtD
Daunorubicin—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.31e-06	0.00025	CcSEcCtD
Daunorubicin—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.31e-06	0.00025	CcSEcCtD
Daunorubicin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.31e-06	0.00025	CcSEcCtD
Daunorubicin—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.3e-06	0.00025	CcSEcCtD
Daunorubicin—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.28e-06	0.000249	CcSEcCtD
Daunorubicin—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.2e-06	0.000247	CcSEcCtD
Daunorubicin—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.12e-06	0.000245	CcSEcCtD
Daunorubicin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.1e-06	0.000245	CcSEcCtD
Daunorubicin—Syncope—Doxorubicin—peripheral nervous system neoplasm	9.07e-06	0.000244	CcSEcCtD
Daunorubicin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.05e-06	0.000243	CcSEcCtD
Daunorubicin—Confusional state—Epirubicin—peripheral nervous system neoplasm	9e-06	0.000242	CcSEcCtD
Daunorubicin—YWHAG—Apoptosis—AKT1—peripheral nervous system neoplasm	8.99e-06	0.000897	CbGpPWpGaD
Daunorubicin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	8.94e-06	0.00024	CcSEcCtD
Daunorubicin—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.93e-06	0.000891	CbGpPWpGaD
Daunorubicin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	8.92e-06	0.00024	CcSEcCtD
Daunorubicin—Oedema—Epirubicin—peripheral nervous system neoplasm	8.92e-06	0.00024	CcSEcCtD
Daunorubicin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	8.89e-06	0.000239	CcSEcCtD
Daunorubicin—Infection—Epirubicin—peripheral nervous system neoplasm	8.86e-06	0.000238	CcSEcCtD
Daunorubicin—Cough—Doxorubicin—peripheral nervous system neoplasm	8.83e-06	0.000237	CcSEcCtD
Daunorubicin—Shock—Epirubicin—peripheral nervous system neoplasm	8.78e-06	0.000236	CcSEcCtD
Daunorubicin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	8.76e-06	0.000236	CcSEcCtD
Daunorubicin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.74e-06	0.000235	CcSEcCtD
Daunorubicin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	8.73e-06	0.000235	CcSEcCtD
Daunorubicin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.71e-06	0.000234	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.64e-06	0.000862	CbGpPWpGaD
Daunorubicin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	8.63e-06	0.000232	CcSEcCtD
Daunorubicin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.61e-06	0.000232	CcSEcCtD
Daunorubicin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.61e-06	0.000232	CcSEcCtD
Daunorubicin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.61e-06	0.000232	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	8.59e-06	0.000857	CbGpPWpGaD
Daunorubicin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.58e-06	0.000231	CcSEcCtD
Daunorubicin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.51e-06	0.000229	CcSEcCtD
Daunorubicin—Anorexia—Epirubicin—peripheral nervous system neoplasm	8.5e-06	0.000229	CcSEcCtD
Daunorubicin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.42e-06	0.000226	CcSEcCtD
Daunorubicin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.33e-06	0.000831	CbGpPWpGaD
Daunorubicin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.32e-06	0.000224	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	8.27e-06	0.000825	CbGpPWpGaD
Daunorubicin—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.26e-06	0.000222	CcSEcCtD
Daunorubicin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.26e-06	0.000222	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	8.24e-06	0.000822	CbGpPWpGaD
Daunorubicin—Infection—Doxorubicin—peripheral nervous system neoplasm	8.2e-06	0.000221	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.13e-06	0.000219	CcSEcCtD
Daunorubicin—Shock—Doxorubicin—peripheral nervous system neoplasm	8.12e-06	0.000218	CcSEcCtD
Daunorubicin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.08e-06	0.000217	CcSEcCtD
Daunorubicin—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.07e-06	0.000217	CcSEcCtD
Daunorubicin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.06e-06	0.000217	CcSEcCtD
Daunorubicin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	7.98e-06	0.000215	CcSEcCtD
Daunorubicin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.95e-06	0.000214	CcSEcCtD
Daunorubicin—Somnolence—Epirubicin—peripheral nervous system neoplasm	7.93e-06	0.000213	CcSEcCtD
Daunorubicin—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	7.93e-06	0.000791	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.87e-06	0.000786	CbGpPWpGaD
Daunorubicin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.87e-06	0.000212	CcSEcCtD
Daunorubicin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.86e-06	0.000784	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	7.83e-06	0.000782	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.78e-06	0.000776	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.76e-06	0.000774	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	7.76e-06	0.000774	CbGpPWpGaD
Daunorubicin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.76e-06	0.000209	CcSEcCtD
Daunorubicin—ABCC1—Disease—GNS—peripheral nervous system neoplasm	7.71e-06	0.000769	CbGpPWpGaD
Daunorubicin—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.69e-06	0.000207	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.67e-06	0.000765	CbGpPWpGaD
Daunorubicin—YWHAG—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	7.64e-06	0.000762	CbGpPWpGaD
Daunorubicin—Pain—Epirubicin—peripheral nervous system neoplasm	7.63e-06	0.000205	CcSEcCtD
Daunorubicin—Constipation—Epirubicin—peripheral nervous system neoplasm	7.63e-06	0.000205	CcSEcCtD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.61e-06	0.00076	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	7.58e-06	0.000756	CbGpPWpGaD
Daunorubicin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.52e-06	0.000202	CcSEcCtD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.5e-06	0.000748	CbGpPWpGaD
Daunorubicin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.47e-06	0.000201	CcSEcCtD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.42e-06	0.00074	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	7.39e-06	0.000738	CbGpPWpGaD
Daunorubicin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.36e-06	0.000198	CcSEcCtD
Daunorubicin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.35e-06	0.000198	CcSEcCtD
Daunorubicin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.34e-06	0.000197	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.3e-06	0.000196	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—HRAS—peripheral nervous system neoplasm	7.21e-06	0.000719	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.18e-06	0.000716	CbGpPWpGaD
Daunorubicin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.18e-06	0.000193	CcSEcCtD
Daunorubicin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.12e-06	0.000191	CcSEcCtD
Daunorubicin—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.09e-06	0.000191	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	7.07e-06	0.000706	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	7.06e-06	0.000705	CbGpPWpGaD
Daunorubicin—Pain—Doxorubicin—peripheral nervous system neoplasm	7.06e-06	0.00019	CcSEcCtD
Daunorubicin—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.06e-06	0.00019	CcSEcCtD
Daunorubicin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.05e-06	0.00019	CcSEcCtD
Daunorubicin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.05e-06	0.00019	CcSEcCtD
Daunorubicin—YWHAG—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	7e-06	0.000699	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.81e-06	0.00068	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.8e-06	0.000183	CcSEcCtD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	6.76e-06	0.000675	CbGpPWpGaD
Daunorubicin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.75e-06	0.000182	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.73e-06	0.000672	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.57e-06	0.000177	CcSEcCtD
Daunorubicin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.56e-06	0.000176	CcSEcCtD
Daunorubicin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	6.56e-06	0.000654	CbGpPWpGaD
Daunorubicin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.53e-06	0.000176	CcSEcCtD
Daunorubicin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.53e-06	0.000176	CcSEcCtD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.47e-06	0.000646	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	6.46e-06	0.000644	CbGpPWpGaD
Daunorubicin—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.4e-06	0.000172	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—AKT1—peripheral nervous system neoplasm	6.36e-06	0.000635	CbGpPWpGaD
Daunorubicin—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.31e-06	0.00017	CcSEcCtD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.3e-06	0.000628	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	6.3e-06	0.000628	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.29e-06	0.000627	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	6.24e-06	0.000623	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	6.19e-06	0.000617	CbGpPWpGaD
Daunorubicin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.1e-06	0.000164	CcSEcCtD
Daunorubicin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.08e-06	0.000164	CcSEcCtD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.05e-06	0.000604	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.05e-06	0.000603	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	5.99e-06	0.000597	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	5.97e-06	0.000595	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	5.96e-06	0.000594	CbGpPWpGaD
Daunorubicin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.92e-06	0.000159	CcSEcCtD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.92e-06	0.000591	CbGpPWpGaD
Daunorubicin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.9e-06	0.000159	CcSEcCtD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.86e-06	0.000585	CbGpPWpGaD
Daunorubicin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.84e-06	0.000157	CcSEcCtD
Daunorubicin—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	5.76e-06	0.000575	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.69e-06	0.000568	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	5.68e-06	0.000567	CbGpPWpGaD
Daunorubicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.67e-06	0.000153	CcSEcCtD
Daunorubicin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.65e-06	0.000152	CcSEcCtD
Daunorubicin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.63e-06	0.000562	CbGpPWpGaD
Daunorubicin—Rash—Epirubicin—peripheral nervous system neoplasm	5.63e-06	0.000151	CcSEcCtD
Daunorubicin—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	5.62e-06	0.000561	CbGpPWpGaD
Daunorubicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.62e-06	0.000151	CcSEcCtD
Daunorubicin—XDH—Metabolism—TH—peripheral nervous system neoplasm	5.61e-06	0.00056	CbGpPWpGaD
Daunorubicin—Headache—Epirubicin—peripheral nervous system neoplasm	5.59e-06	0.00015	CcSEcCtD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.48e-06	0.000547	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	5.48e-06	0.000547	CbGpPWpGaD
Daunorubicin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.46e-06	0.000147	CcSEcCtD
Daunorubicin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	5.45e-06	0.000543	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.42e-06	0.00054	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	5.39e-06	0.000538	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	5.39e-06	0.000538	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.38e-06	0.000536	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.32e-06	0.000531	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.32e-06	0.000531	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.31e-06	0.00053	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	5.31e-06	0.00053	CbGpPWpGaD
Daunorubicin—Nausea—Epirubicin—peripheral nervous system neoplasm	5.3e-06	0.000143	CcSEcCtD
Daunorubicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.25e-06	0.000141	CcSEcCtD
Daunorubicin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	5.24e-06	0.000523	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	5.21e-06	0.000519	CbGpPWpGaD
Daunorubicin—Rash—Doxorubicin—peripheral nervous system neoplasm	5.21e-06	0.00014	CcSEcCtD
Daunorubicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.2e-06	0.00014	CcSEcCtD
Daunorubicin—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	5.19e-06	0.000518	CbGpPWpGaD
Daunorubicin—Headache—Doxorubicin—peripheral nervous system neoplasm	5.17e-06	0.000139	CcSEcCtD
Daunorubicin—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.02e-06	0.000501	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	4.95e-06	0.000493	CbGpPWpGaD
Daunorubicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.9e-06	0.000132	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	4.9e-06	0.000489	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.77e-06	0.000475	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—peripheral nervous system neoplasm	4.75e-06	0.000474	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.72e-06	0.000471	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—peripheral nervous system neoplasm	4.69e-06	0.000468	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.68e-06	0.000467	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	4.67e-06	0.000466	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.63e-06	0.000462	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	4.58e-06	0.000457	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	4.49e-06	0.000448	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.42e-06	0.000441	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	4.4e-06	0.000439	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.25e-06	0.000424	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.2e-06	0.000419	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	4.14e-06	0.000413	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.1e-06	0.000409	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	4.07e-06	0.000406	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	3.91e-06	0.00039	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	3.9e-06	0.000389	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—peripheral nervous system neoplasm	3.9e-06	0.000389	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.87e-06	0.000387	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.85e-06	0.000384	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.78e-06	0.000377	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	3.76e-06	0.000376	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	3.76e-06	0.000375	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	3.71e-06	0.00037	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.69e-06	0.000368	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.56e-06	0.000356	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.55e-06	0.000354	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.5e-06	0.000349	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	3.44e-06	0.000343	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.41e-06	0.00034	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.39e-06	0.000338	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	3.38e-06	0.000337	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	3.32e-06	0.000331	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	3.31e-06	0.000331	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	3.3e-06	0.00033	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.26e-06	0.000325	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.23e-06	0.000323	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.2e-06	0.000319	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.2e-06	0.000319	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.15e-06	0.000315	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	3.11e-06	0.00031	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	3.07e-06	0.000306	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.05e-06	0.000304	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	3.01e-06	0.0003	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.94e-06	0.000294	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	2.91e-06	0.00029	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.88e-06	0.000287	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.83e-06	0.000283	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.82e-06	0.000281	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.77e-06	0.000277	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.75e-06	0.000274	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	2.73e-06	0.000273	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	2.73e-06	0.000272	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	2.71e-06	0.00027	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.68e-06	0.000268	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.62e-06	0.000261	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.58e-06	0.000257	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	2.54e-06	0.000253	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.53e-06	0.000252	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.49e-06	0.000248	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	2.47e-06	0.000246	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.45e-06	0.000245	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.45e-06	0.000245	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.41e-06	0.00024	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.35e-06	0.000235	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.33e-06	0.000232	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.26e-06	0.000226	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	2.23e-06	0.000223	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.21e-06	0.00022	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.19e-06	0.000219	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.17e-06	0.000216	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	2.1e-06	0.00021	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	2.08e-06	0.000208	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.07e-06	0.000207	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.99e-06	0.000198	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.97e-06	0.000196	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.96e-06	0.000195	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.89e-06	0.000189	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.88e-06	0.000187	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.86e-06	0.000186	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	1.85e-06	0.000185	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.81e-06	0.000181	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.75e-06	0.000175	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.75e-06	0.000174	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	1.66e-06	0.000166	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.6e-06	0.00016	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.57e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.57e-06	0.000157	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-06	0.000151	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.5e-06	0.00015	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.49e-06	0.000148	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-06	0.000148	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.48e-06	0.000147	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	1.27e-06	0.000126	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.26e-06	0.000125	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	1.24e-06	0.000123	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.21e-06	0.00012	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.2e-06	0.000119	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.18e-06	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	1.18e-06	0.000118	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.15e-06	0.000114	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.69e-07	9.66e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.63e-07	9.61e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.45e-07	9.43e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	9.26e-07	9.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.24e-07	9.22e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	9.11e-07	9.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.11e-07	9.09e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	8.18e-07	8.16e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.43e-07	7.42e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.3e-07	7.28e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	6.85e-07	6.83e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.62e-07	6.61e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	6.02e-07	6.01e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	5.96e-07	5.95e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	4.32e-07	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-07	4.07e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.26e-07	3.25e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.6e-07	2.59e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.01e-07	2e-05	CbGpPWpGaD
